Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-001550Source: DataRank Database

Impact of COVID-19 on patients with rheumatic complications of cancer immunotherapy: results of a registry survey is a research paper published in Journal for ImmunoTherapy of Cancer (2020). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)OA: goldTopics (32)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Aidan Tirpack ORCID,Karmela K Chan ORCID,Anne R. Bass ORCID,Nilasha Ghosh ORCID

Live enrichment

PubMed:33067320 PMC:PMC7569707

Nilasha Ghosh

Grant: NIH/NCATS UL1-TR-0023849

NCATS NIH HHS

Grant: UL1 TR002384

goldLicense: cc-by

publisherhttps://jitc.bmj.com/content/jitc/8/2/e001550.full.pdf

publisherhttps://syndication.highwire.org/content/doi/10.1136/jitc-2020-001550

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7569707

repositoryhttps://doaj.org/article/1fbe36c93c0b49d09ac713e70b2e374a

Europe_PMChttps://europepmc.org/articles/PMC7569707

MeSH Terms

HumansPneumonia, ViralCoronavirus InfectionsNeoplasmsRheumatic DiseasesImmunosuppressive AgentsClinical Laboratory TechniquesSeverity of Illness IndexRegistriesIncidenceProspective StudiesMedical OncologyAgedMiddle AgedNew York CityFemaleMalePandemicsCTLA-4 AntigenProgrammed Cell Death 1 ReceptorSurveys and QuestionnairesPractice Patterns, Physicians'Clinical Decision-MakingBetacoronavirusAntineoplastic Agents, ImmunologicalB7-H1 AntigenCOVID-19SARS-CoV-2COVID-19 Testing

Keywords

ImmunotherapyAutoimmunityProgrammed Cell Death 1 Receptor